The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes
Abstract
Inflammation has been implicated in neurodegenerative disorders such as Alzheimer's disease (AD). The main inflammatory players in AD are the glial cells which initiate the inflammatory response. One of the earliest neuropathological changes in AD is the accumulation of astrocytes at sites of A beta deposition. It is desirable to find methods of tipping the balance towards anti-inflammatory state. Estrogenic compounds have shown anti-inflammatory and also antioxidant activity. Astrocytes were pretreated with 17-beta estradiol or with genistein, and 48 h later treated with 5 microM amyloid beta (A beta) for 24 h. We found that A beta induces inflammatory mediators, such as cyclooxygenase 2 (COX-2), inducible nitric oxide synthase (iNOS), interleukin 1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha). All these effects were prevented when cells were pretreated with estradiol or genistein, demonstrating anti-inflammatory effects of estradiol or genistein in astrocytes in primary culture. The A beta-stimulated expression of pro-inflammatory genes in cells is antagonized by the action of the PPARs (peroxisome proliferator activated receptors). Here we detected an increase in PPAR-gamma expression in astrocytes in primary culture treated with A beta and estradiol or soy isoflavone genistein. Thus, some of the anti-inflammatory effects of estrogenic compounds may be mediated and activated by PPARs suppressing a diverse array of inflammatory responses caused by A beta in astrocytes in primary culture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the increased levels of IL-1β and TNF-α induced by Aβ were modulated treating astrocytes with genistein (Valles et al., 2010)”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Valles et al., 2010
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
A simplification of the protein assay method of Lowry et al. which is more generally applicable
Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,531
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Borrás, C., Sastre, J., García-Sala, D., Lloret, A., Pallardó, F. V., & Viña, J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01356-4 · Cited by 654
Inflammation and the Degenerative Diseases of Aging
McGeer, P. L., & McGeer, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 530
Alzheimer Disease and Oxidative Stress
Perry, G., Cash, A. D., & Smith, M. A. (2002) · BioMed Research International · doi:10.1155/s1110724302203010 · Cited by 455
Cited by
Sorted by citations
Items 101–187 of 187
Bianco, F., Tonna, N., Lovchik, R. D., Mastrangelo, R., Morini, R., Ruiz, A., Delamarche, E., & Matteoli, M. (2012) · Analytical Chemistry · doi:10.1021/ac302094z · Cited by 28
Lee, J., Nam, J. H., Nam, Y., Nam, H. Y., Yoon, G., Ko, E., Kim, G.-C., Bautista, M. R., Capule, C. C., Koyanagi, T., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1321-3 · Cited by 28
Crosstalk between phytochemicals and inflammatory signaling pathways
Prasad, S., Kumar, V., Singh, C., & Singh, A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01206-z · Cited by 29
Al‐Shami, A. S., Essawy, A. E., & Elkader, H. A. E. A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7870 · Cited by 29
Xu, M., Liu, J., Zhu, C., Gao, Y., Zhao, S., Liu, W., & Zhang, Y. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-015-9398-0 · Cited by 26
Estrogen attenuates renal IRI through PPAR-γ agonism in rats
Singh, A. P., Singh, N., & Bedi, P. M. S. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.02.038 · Cited by 25
Kim, H., & Lee, D.-G. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-11003-1 · Cited by 19
Zarini-Gakiye, E., Amini, J., Sanadgol, N., Vaezi, G., & Kazem, P. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200422090135 · Cited by 22
Ordoñez, W. O. C., Palomino, N. V., Takahashi, C. S., & Giuliatti, S. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00243-8 · Cited by 22
Issa, N. T., Kruger, J., Wathieu, H., Raja, R., Byers, S. W., & Dakshanamurthy, S. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1065-y · Cited by 22
Moriyama, M., Hashimoto, A., Satoh, H., Kawabe, K., Mizue, O., Takano, K., & Nakamura, Y. (2018) · International Journal of Inflammation · doi:10.1155/2018/8496973 · Cited by 21
Chatterjee, G., Roy, D., Khemka, V. K., Chattopadhyay, M., & Chakrabarti, S. (2015) · Aging and Disease · doi:10.14336/ad.2015.0327 · Cited by 20
HIF1a Inhibitor Rescues Acute-on-Chronic Liver Failure
Xie, F., Dong, J., Zhu, Y., Kefei, W., Liu, X., Chen, D., & Meng, Q. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.03.007 · Cited by 20
Gene expression‐targeted isoflavone therapy
Węgrzyn, A. (2012) · IUBMB Life · doi:10.1002/iub.1007 · Cited by 18
Yassa, N. W., Khalil, S., Saleh, S. R., Ghareeb, D. A., Demellawy, M. E., & El-Sayed, M. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237929 · Cited by 17
RetractedGong, G., Ganesan, K., Wan, Y., Liu, Y., Huang, Y., Luo, Y., Wang, X. M., Zhang, Z., & Zheng, Y. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2357701 · Cited by 19
Xi, Y., Li, X.-Y., Yu, H., Jing, H., Ma, W., Yuan, L., Zhang, D.-D., Wu, J., & Xiao, R. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1319-x · Cited by 15
Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice
Jorda, A., Aldasoro, M., Aldasoro, C., & Vallés, S. L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210489 · Cited by 16
Free radicals in Alzheimer's disease: From pathophysiology to clinical trial results
Viña, J., Borrás, C., & Mas‐Bargues, C. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.051 · Cited by 15
Viña, J., Borrás, C., & Mas‐Bargues, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240308 · Cited by 14
de Ávila, A. R. A., de Queirós, L. D., Ueta, T. M., Macêdo, G. A., & Macedo, J. A. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.12850 · Cited by 14
Jimenez‐Vergara, A. C., Drunen, R. V., Cagle, T., & Munoz‐Pinto, D. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-77655-1 · Cited by 14
Ibrahim, B. A., Alenazi, F., & Briski, K. P. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.068 · Cited by 14
Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity
Kumaraswamy, P., Sethuraman, S., & Krishnan, U. M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912211 · Cited by 14
Shambayati, M., Patel, M. C., Ma, Y., Cunningham, R. L., & Schreihofer, D. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.042 · Cited by 14
Rahman, M. A., Rahman, M. H., Rhim, H., & Kim, B. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240426091311 · Cited by 14
Menze, E. T., Esmat, A., Tadros, M. G., Khalifa, A. E., & Abdel‐Naim, A. B. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.007 · Cited by 13
RetractedNeuroprotective and Preventative Effects of Molecular Hydrogen
Noda, M., Liu, J., & Long, J. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201019103020 · Cited by 13
Jafari, A., Esmaeilzadeh, Z., Khezri, M. R., Ghasemnejad‐Berenji, H., Pashapour, S., Sadeghpour, S., & Ghasemnejad‐Berenji, M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14345 · Cited by 12
El‐Bana, M. A., El‐Daly, S. M., Omara, E. A. A., Morsy, S., El‐Naggar, M. E., & Medhat, D. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106730 · Cited by 11
Therapeutic potential of berries in age-related neurological disorders
Norouzkhani, N., Afshari, S., Sadatmadani, S.-F., Mollaqasem, M. M., Mosadeghi, S., Ghadri, H., Fazlizade, S., Alizadeh, K., Javar, P. A., Amiri, H., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1348127 · Cited by 12
Gen inhibiting the Wnt/Ca2+ signaling pathway alleviates cerebral ischemia/reperfusion injury
Li, L., Liu, S., Wang, M., Li, M., Liu, Y., Chen, H., Chen, J., Tao, W., Huang, L., & Zhao, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-88136-8 · Cited by 11
Alarcón‐Aguilar, A., González‐Puertos, V. Y., Luna‐López, A., López-Macay, Á., Morán, J., Santamarı́a, A., & Königsberg, M. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2841 · Cited by 11
A cross-species analysis method to analyze animal models' similarity to human's disease state
Yu, S., Zheng, L., Li, Y., Li, C., Ma, C., Li, Y., Li, X., & Hao, P. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-s3-s18 · Cited by 11
Supakul, S., Oyama, C., Hatakeyama, Y., Maeda, S., & Okano, H. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.018 · Cited by 10
Anti-amnesic and Neuroprotective Potential of Genistein Against Alzheimer’s Disease
Singh, N. K., Verma, N. K., Gupta, J. K., & Raghav, J. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00452-0 · Cited by 10
Ronchetti, S., Labombarda, F., Core, J. D., Roig, P., Nicola, A. F. D., & Pietranera, L. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13480 · Cited by 8
Enayati, M., Stride, E., Edirisinghe, M. J., & Bonfield, W. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.154 · Cited by 8
Astrocytes and Inflammatory Processes in Alzheimer’s Disease
Vallés, S. L., Burguet, F., Iradi, A., Aldasoro, M., Vila, J. M., Aldasoro, C., & Jorda, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88701 · Cited by 9
Dayem, S. M. A. E., Ahmed, H. H., Metwally, F. M., Foda, F., Shalby, A. B., & Zaazaa, A. M. (2012) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2012.02.002 · Cited by 8
Khan, N., Monagas, M., Urpí-Sardà, M., Llorach, R., & Andrés‐Lacueva, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397156-2.00256-8 · Cited by 7
An outlook on the target‐based molecular mechanism of phytoconstituents as immunomodulators
Noor, G., Badruddeen, B., Akhtar, J., Singh, B., Ahmad, M., & Khan, M. I. (2023) · Phytotherapy Research · doi:10.1002/ptr.7969 · Cited by 9
Anderson, G., & Maes, M. H. J. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch13 · Cited by 7
Forouzanfar, F., Pourbagher‐Shahri, A. M., Vafaee, F., Sathyapalan, T., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230504121523 · Cited by 6
Lei, H., Dong, X., & Gao, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01891 · Cited by 8
Li, K., Zhang, S., Sun, Y., Chen, Y., Chen, W., Ruan, W., & Liu, Y. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23055 · Cited by 6
Pharmacotherapeutic potential of soy isoflavones in neurological disorders
Mokhtari, M., Qolipour, F., Yousefi, A. H., Alijanzadeh, D., Kasnavi, Q., Sadeghi, T., Akbarzadeh, D., Fallahi, M. S., & Deravi, N. (2022) · Neurology Asia · doi:10.54029/2022psy · Cited by 6
Ronchetti, S., Labombarda, F., Roig, P., Nicola, A. F. D., & Pietranera, L. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13228 · Cited by 6
Neuroprotection by Exogenous Estrogenic Compounds Following Traumatic Brain Injury
López-Rodríguez, A. B., Ávila-Rodriguez, M., Vega-Vela, N. E., Capani, F., González, J., García‐Segura, L. M., & Barreto, G. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801479-0.00006-1 · Cited by 6
New Technique in Tendon Sport Recovery. Percutaneous Electrolysis Intratissue (EPI®)
Colmena, C. (2013) · International Journal of Physical Medicine & Rehabilitation · doi:10.4172/2329-9096.1000113 · Cited by 5
Oppong‐Gyebi, A., Metzger, D. B., Vann, P. H., Yockey, R. A., Sumien, N., & Schreihofer, D. A. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105201 · Cited by 5
Neuroprotection by Dietary Isoflavones and Their Role in Cerebral Ischemia
Schreihofer, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00039-4 · Cited by 5
Pascua, P., Camello‐Almaraz, C., Pozo, M. J., Martín‐Cano, F. E., Vara, E., Fernández-Tresguerres, J. Á., & Camello, P. J. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0138-7 · Cited by 5
Astrocytes and the Important Role in the Future Research of Brain
Vallés, S. L. (2012) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000e127 · Cited by 4
Is antioxidant therapy effective to treat alzheimer's disease?
Lloret, A., Giraldo, E., & Viña, J. (2011) · Free Radicals and Antioxidants · doi:10.5530/ax.2011.4.3 · Cited by 4
Immunostimulatory Potential of Natural Compounds and Extracts: A Review
Stroe, A. C., & Oancea, S. (2019) · Current Nutrition & Food Science · doi:10.2174/1573401315666190301154200 · Cited by 4
Estrogenic Regulation of Glia and Neuroinflammation
Crespo‐Castrillo, A., Arévalo, M., García‐Segura, L. M., & Yanguas‐Casás, N. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190645908.003.0008 · Cited by 3
Sirichaiwetchakoon, K., Suksuphew, S., Srisawat, R., & Eumkeb, G. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2703138 · Cited by 3
Derangula, M., Ruhinaz, K. K., Panati, K., Subramani, P. A., Tatireddigari, V. R. R. A., & Narala, V. R. (2022) · The Natural Products Journal · doi:10.2174/2210315512666220907150542 · Cited by 3
Plant-Derived Antiinflammatory Steroid Analogs for Neuroprotection
Şöhretoğlu, D., & Arroo, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00007-0 · Cited by 3
Yao, X., Zeng, W., Zhu, Y., Zheng, F., Xiao, C., & Liu, X. (2021) · Medicinal Chemistry · doi:10.2174/1573406417666210830114715 · Cited by 3
Healthy Nutrition, Phytonutrients and Alzheimer’s Disease
Aldasoro, M. (2011) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.1000e102 · Cited by 2
ISOFLAVONES AND ALZHEIMER’S DISEASE: THE EFFECTS OF SOY IN DIET
Habib, S., Afridi, A. A. K., Wasay, M., & Iqbal, R. (2014) · eCommons - AKU (Aga Khan University) · Cited by 2
APP /Aβ Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease
Jáuregui, G. V., Coomes, S., Emmett, E., Thatcher, A., Oyelakin, N., Čarná, M., Zelinková, J., Novotný, J., Polakova, N., Kuruvilla, T., et al. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70526 · Cited by 1
Chances in the Brain Cells, From Epigenetic To the Future
Soraya, L. V. (2014) · Gene Technology · doi:10.4172/2329-6682.1000e108 · Cited by 1
Vallés, S. L., Singh, S. K., Campo-Palacio, I., & Jorda, A. (2021) · Preprints.org · doi:10.20944/preprints202106.0241.v1
Ju, X., Metzger, D. B., & Jung, M. E. (2012) · InTech eBooks · doi:10.5772/27725
Glia, Next Research Brain Frontier
Vallés, S. L. (2013) · Biochemistry & Physiology Open Access · doi:10.4172/2168-9652.1000e117
Neuroprotective Effect of Genistein : Studies in Rat Models of Parkinson’s and Alzheimer’s Disease
Bagheri, M. (2012) · DiVA (Linkoping University)
Prospecção e obtenção de compostos com potencial terapêutico, a partir de subprodutos industriais
Tavares, F. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Park, G. H., & Jang, J. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_21
ACUTE PAINT THINNER TREATMENT INDUCES CELL DEATH IN CULTURED NEURONS AND ASTROCYTES
Malloul, H. (2016) · International Journal of Research in Engineering and Technology · doi:10.15623/ijret.2016.0509059
Karimi, S., Hosseini, M., Mahdian, Z., & Babazadeh, B. (2017) · Annals of Medical and Health Sciences Research
Treating multiple antiaging pathways improves health markers in open label clinical study
Villeponteau, B., & Still, Y. L. (2017) · Translational Medicine Communications · doi:10.1186/s41231-017-0018-4
MaCheng-cheng, W.-W., Zhou, H., YuYuan-di, H.-L., Ding, X., & Xiao, X. (2013)
Route 66 in New Mexico: A Select Guide to Museum, Archival, and Library Resources
Davidson, R. (2008) · UNM’s Digital Repository (University of New Mexico)
Genistein effect on cognition in early Alzheimer’s disease patients. The GENIAL clinical trialPreprint
Viña, J., Escudero, J. V., Baquero, M., Carbonell‐Asins, J. A., Tarazona‐Santabalbina, F. J., Cebrián, M., Muñoz, J. E., Satorres, E., Meléndez, J. C., Rebolleda, J. F., et al. (2022) · medRxiv · doi:10.1101/2022.06.01.22275832
Yu, H., Han, G., Sun, M., & Ma, T. (2022) · Future Integrative Medicine · doi:10.14218/fim.2022.00039
Genistein and its use as a neuroprotective agent in stroke
Oppong‐Gyebi, A., & Schreihofer, D. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00048-2
Pharmacological Interventions for Maintaining Brain Health in Ageing
Sathaye, S. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_14
Majou, D., & Dermenghem, A.-L. (2025) · OCL · doi:10.1051/ocl/2025032
A study of neurodegeneration and neuroprotection in Nothobranchius guentheri
Genade, T. (2012) · Open University of Cape Town (University of Cape Town)
Viña, J., Escudero, J., Baquero, M., Cebrián, M., Carbonell-Asíns, J. A., Muñoz, J. E., Satorres, E., Melendez, J. C., Ferrer-Rebolleda, J., Cózar-Santiago, M. D. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21500779
Al‐Amgad, Z., Jad, M., Al-Amgad, H., basher, A. W., Mohammed, H. A., El-Aziz, A. A. A., Mohammed, E. S. I., & Madkour, F. A. (2026) · Microscopy and Microanalysis · doi:10.1093/mam/ozag001
Wu, Q., Li, L., Lei, Y.-Q., Zhou, T., Tang, H.-L., Zhang, B.-Y., Lu, Y.-W., Salvatore, M., Zhang, D.-Z., Tong, J.-Y., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106466
Genistein as a potential hormetic regulator of proteostasis in neurodegeneration and aging
Dash, R., Mitra, S., Lee, J., Bashar, M. A., Sohel, M., Tran, N.-N., Lee, J.-C., Lee, S. B., & Lee, B. (2026) · Chinese Medical Journal BioMed · doi:10.65457/cmjbm-2026-0009
Metadata
- Authors
- Valles, S. L., Dolz-Gaiton, P., Gambini, J., Borras, C., LLoret, A., Pallardo, F. V., & Viña, J.
- Affiliations
- Universitat de València (ES)
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 1312
- Pages
- 138-144
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2069905837
- Cited by
- 186
- References
- 45
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 10 · 2023: 11 · 2022: 16 · 2021: 14 · 2020: 14 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 13 · 2015: 9 · 2014: 15 · 2013: 11 · 2012: 18
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- local and national government of Spain (GVcs2007-AP-001, BFU 2005/230, BFU 2007 6583/BFI)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- Alzheimer's disease, astrocytes, estradiol, genistein, amyloid-beta, neuroinflammation, PPARγ, estrogenic compounds, cyclooxygenase-2, inducible nitric oxide synthase, IL-1β, TNF-α, soy isoflavones, anti-inflammatory activity
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Cerebral Cortex, Dose-Response Relationship, Drug, Drug Interactions, Enzyme-Linked Immunosorbent Assay, Estradiol, Estrogens, Gene Expression Regulation, Peptide Fragments, Tumor Necrosis Factor-alpha, Amyloid beta-Peptides, Genistein, Protein Kinase Inhibitors, PPAR gamma, Rats, Cyclooxygenase 2, Nitric Oxide Synthase Type II, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review